NCT00574925View on ClinicalTrials.gov

Study to Assess Management Strategies for the Use of Esomeprazole (Nexium) in Helicobacter Pylori Infected Patients

PHASE4CompletedINTERVENTIONAL
Timeline

Start Date

November 30, 2003

Study Completion Date

October 31, 2007

Conditions
Gastroesophageal Reflux Disease (GERD)
Interventions
DRUG

Esomeprazole

Trial Locations (1)

Unknown

University Hospital Zurich, Zurich

Sponsors

Collaborators (1)

AstraZeneca
All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

lead

University of Zurich

OTHER

NCT00574925 - Study to Assess Management Strategies for the Use of Esomeprazole (Nexium) in Helicobacter Pylori Infected Patients | Biotech Hunter | Biotech Hunter